A TP53 mutation was found exclusively in the CMTC part, while the poorly differentiated component showed a clonal evolution, harboring an activating PIK3CA mutation and copy number gains of BRCA2, FGF23, FGFR1, and PIK3CB—alterations which are typically seen in squamous cell carcinoma. Here, BRCA2 is linked to squamous cell carcinoma.